Genetic counseling in hereditary non-polyposis colorectal cancer

Tumori

Volumn 82, Issue 2, 1996, Pages 136-142

  Heouaine, Abdelhamid ^a   Mareni, Cristina ^b   Varesco, Liliana ^a   Genuardi, Maurizio ^c   Neri, Giovanni ^c,d  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

cancer; DNA repair; genetic counseling; genetic testing

Indexed keywords

COLORECTAL CANCER; DNA REPAIR; GENETIC COUNSELING; GENETIC DISORDER; HUMAN; REVIEW;

EID: 0030004034     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169608200207     Document Type: Review

References (31)

1. Biesecker B.B., Boehnke M., Calzone K., Markel D.S., Garber J.E., Collins F.S., Weber B.L.: Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA, 269: 1970-1974, 1993.
2. Bishop P.T.: The importance of inherited predisposition to cancer. Cancer Topics, 8: 66-68, 1991.
3. Bronner C.E., Baker S.M., Morrison P.T., Warren G., Smith L.G., Lescoe M.K., Kane M., Earabino C., Lipford J., Linderblom A., Tannergärd P., Bollag R.J., Godwin A.R., Ward D.C., Nordenskjold M., Fishel R., Kolodner R., Liskay R.M.: Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature, 368: 258-261, 1994.
4. Claus E.B., Risch N.J., Thompson W.D.: Age at onset as an indicator of familial risk of breast cancer. Am. J. Epidemiol., 131: 961-972, 1990.
5. Eisinger F., Thouvenin D., Bignon Y.J., Cuisenier J., Feingold J., Hoerni B., Lasset C., Lyonnet D., Maraninchi D., Marty M., Mattei J.F., Sobol H., Maugard-Louboutin C., Nogues C., Pujol H., Philip T.: Reflexions sur l'organisation des consultations d'oncogénètique (premiére étape vers la publication de bonnes pratiques cliniques). Bull. Cancer, 82: 865-878, 1995.
6. Ellis N.A., Groden J., Ye T.Z., Straughen J., Lennon D.J., Ciocci S., Proytcheva M., German J.: The Bloom's syndrome gene product is homologous to RecQ helicases. Cell, 83: 655-666, 1995.
7. Fishel R., Lescoe M.K., Rao M.R.S., Copeland N.G., Jenkins N.A., Garber J., Kane M., Kolodner R.: The human mutator gene homolog MSH2 and its association with hereditary non-polyposis colon cancer. Cell, 75: 1027-1038, 1993.
8. Hamilton S.R., Liu B., Parsons R.E., Papadopoulos N., Jen J., Powell S.M., Krush A.J., Berk T., Cohen Z., Tetu B., Burger P.C., Wood P.A., Taqi F., Booker S.V., Petersen G.M., Offerhaus G.J.A., Tersmette A.C., Giardiello F.M., Vogelstein B., Kinzler K.W.: The molecular basis of Turcot's syndrome. N. Engl. J. Med., 332: 839-847, 1995.
9. Harper P.S.: Practical Genetic Counselling, 3rd edition. Wright, Butterworth & Co., London, 1988.
10. Khoury M.J., Beatty T.H., Liang K.Y.: Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? Am. J. Epidemiol., 127: 674-683, 1988.
11. Knudson A.G.: Hereditary cancers: clue to mechanisms of carcinogenesis. Br. J. Cancer, 59: 661-666, 1989.
12. Leach F.S., Nicolaides N.C., Papadopoulos N., Liu B., Jen J., Parsons R., Peltomäki P., Sistonen P., Aaltonen L.A., Nyström-Lahti M., Guan X.Y., Zhang J., Meltzer P.S., Yu J.W., Kao F.T., Chen D.J., Cerosaletti K.M., Fournier R.E.K., Todd S., Lewis T., Leach R.J., Naylor S.L., Weissenbach J., Mecklin J.P., Järvinen H., Petersen G.M., Hamilton S.R., Green J., Jass J., Watson P., Lynch H.T., Trent J.M., de la Chapelle A., Kinzler K.W., Vogelstein B.: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell, 75: 1215-1225, 1993.
13. Liu B., Nicolaides N.C., Markowitz S., Willson J.K.V., Parsons R.E., Jen J., Papadopolous N., Peltomäki P., de la Chapelle A., Hamilton S.R., Kinzler K.W., Vogelstein B.: Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet., 9: 48-55, 1995.
14. Liu B., Farrington S.M., Petersen G.M., Hamilton S.R., Parsons R., Papadopoulos N., Fujiwara T., Jin J., Kinzler K.W., Wyllie A.H., Vogelstein B., Dunlop M.G.: Genetic instability occurs in the majority of young patients with colorectal cancer. Nature Med., 1: 348-352, 1995.
15. Lynch H.T.: Genetics, etiology, and human cancer. Prev. Med., 9: 231-243, 1980.
16. Lynch H.T., Smyrk T.C., Watson P., Lanspa S.J., Lynch J.F., Lynch P.M., Cavalieri R.J., Boland C.R.: Genetics, natural history, tumor spectrum and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology, 104: 1535-1549, 1993.
17. Markham A.F., Coletta P.L., Robinson P.A., Clissold P., Taylor G.R., Carr I.M., Meredith D.M.: Screening for cancer predisposition. Eur. J. Cancer, 13: 2015-2029, 1994.
18. Menko F.H.: Genetics of colorectal cancer for clinical practice. Kluwer Academic Publisher, Dordrecht, Boston, London, 1993.
19. Mulhivill J.J.: Prospects for cancer control and prevention through genetics. Clin. Genet., 36: 313-319, 1989.
20. Murday V.: Genetic counselling in the cancer family clinic. Eur. J. Cancer, 13: 2012-2015, 1994.
21. Murday V.A., Slack J.: Inherited disorders associated with colorectal cancer. Cancer Surv., 8: 139-159, 1989.
22. Nicolaides N.C., Papadopoulos N., Liu B., Wei Y.F., Carter K.C., Ruben S.M., Rosen C.A., Haseltine W.A., Fleischmann R.D., Fraser C.M., Adams M.D., Venter J.C., Dunlop M.G., Hamilton S.R., Petersen G.M., de la Chapelle A., Vogelstein B., Kinzler K.W.: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature, 371: 75-80, 1994.
23. Report of a Working Party of the Clinical Genetics Society (UK). Chairman: Dr Angus Clarke: The genetic testing of children. J. Med. Genet., 31: 785-797, 1994.
24. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S., Ashkenazi M., Pecker I., Frydman M., Harnik R., Patanjali S.R., Simmons A., Clines G.A., Sartiel G.A., Gatti R.A., Chessa L., Sanal O., Lavin M.F., Jaspers N.G.J., Taylor A.M.R., Arlett C.F., Miki T., Weissman S.M., Lovett M., Collins F.S., Shiloh Y.: A single ataxia-teleangiectasia gene with a product similar to PI-3 kinase. Science, 268: 1749-1753, 1995.
25. St. John D.V.B., McDermott F.T., Hopper V.L., Debney E.A., Johnson W.R., Hughes E.S.R.: Cancer risk in relatives of patients with common colorectal cancer. Ann. Intern. Med., 118: 785-790, 1993.
26. Swift M.: Malignant neoplasms in heterozygous carriers of genes for certain autosomal recessive syndromes. In: Genetics of human cancer, Mulhivill J.J., Miller R.W., Fraumeni J.F. (Eds.), pp. 209-215, Raven Press, New York, 1977.
27. Swift M., Reitnauer P.J., Morrel D., Chase C.L.: Breast and other cancers in families with ataxia-telangiectasia. N. Engl. J. Med., 316: 1289-1294, 1987.
28. Tabarrok A.: Genetic testing: an economic and contractarian analysis. J. Health Econ., 13: 75-91, 1994.
29. Toribara N.W., Sleisenger M.H.: Screening for colorectal cancer. N. Engl. J. Med., 322: 861-867, 1995.
30. Vasen H.F.A., Mecklin J.P., Meera Khan P., Lynch H.T.: The International Collaborative Group on hereditary non-polyposis colorectal cancer. Dis. Colon Rectum, 34: 424-425, 1991.
31. Watson P., Lynch H.T.: The tumor spectrum in HNPCC. Anticancer Res., 14: 1635-1639, 1994.